Treating mesothelioma in 2021: what is the role of surgery and immunotherapy?

A. Bibby (Bristol (Avon), United Kingdom)

Source: Virtual Congress 2021 – Hot news from the pleura

Session: Hot news from the pleura
Session type: Hot topics
Number: 2878

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bibby (Bristol (Avon), United Kingdom). Treating mesothelioma in 2021: what is the role of surgery and immunotherapy?. Virtual Congress 2021 – Hot news from the pleura

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Surgery for mesothelioma: is curative surgery the past or the future? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014
Surgery for mesothelioma: who are the long-term survivors? Source: Breathe 2009; 6: 66 Year: 2009
Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010
Which immunotherapy for which patients? Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016
Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014
Follow-up after lung cancer resection: is intensified also justified? Source: Eur Respir J 2013; 42: 1178-1179 Year: 2013
What is the best oncological management strategy for mesothelioma in 2018? Source: International Congress 2018 – Malignant pleural effusions Year: 2018
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016
Malignant pleural mesothelioma: new treatments, new hopes? Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017 Year: 2017
VATS in lung cancer treatment: for which patients? Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases Year: 2014
Surgery: a key role in the treatment of lung metastases Source: Annual Congress 2004 - Lung metastases Year: 2004
Combination immunotherapy in mesothelioma: managing expectations and new toxicities Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021